HCAT Valuation

Health Catalyst Inc

Add to Watchlist

Advanced Chart

3.390

-0.26(-7.123%)1D

Overview
Forecast
Valuation
Earnings

HCAT Relative Valuation

HCAT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HCAT is overvalued; if below, it's undervalued.

Historical Valuation

Health Catalyst Inc (HCAT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.85 is considered Undervalued compared with the five-year average of -30.42. The fair price of Health Catalyst Inc (HCAT) is between 15.29 to 36.14 according to relative valuation methord. Compared to the current price of 3.50 USD , Health Catalyst Inc is Undervalued By 77.14%.

Relative Value

Fair Zone

15.29-36.14

Current Price：3.50

77.14%

Undervalued

8.96

Trailing

Forward

6.79

EV/EBITDA

Health Catalyst Inc. (HCAT) has a current EV/EBITDA of 6.79. The 5-year average EV/EBITDA is -94.06. The thresholds are as follows: Strongly Undervalued below -403.48, Undervalued between -403.48 and -248.77, Fairly Valued between 60.65 and -248.77, Overvalued between 60.65 and 215.37, and Strongly Overvalued above 215.37. The current Forward EV/EBITDA of 6.79 falls within the Historic Trend Line -Fairly Valued range.

-12.23

EV/EBIT

Health Catalyst Inc. (HCAT) has a current EV/EBIT of -12.23. The 5-year average EV/EBIT is -9.88. The thresholds are as follows: Strongly Undervalued below -22.15, Undervalued between -22.15 and -16.02, Fairly Valued between -3.75 and -16.02, Overvalued between -3.75 and 2.39, and Strongly Overvalued above 2.39. The current Forward EV/EBIT of -12.23 falls within the Historic Trend Line -Fairly Valued range.

0.84

Health Catalyst Inc. (HCAT) has a current PS of 0.84. The 5-year average PS is 3.79. The thresholds are as follows: Strongly Undervalued below -2.56, Undervalued between -2.56 and 0.61, Fairly Valued between 6.97 and 0.61, Overvalued between 6.97 and 10.15, and Strongly Overvalued above 10.15. The current Forward PS of 0.84 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Health Catalyst Inc. (HCAT) has a current P/OCF of 0.00. The 5-year average P/OCF is -61.30. The thresholds are as follows: Strongly Undervalued below -302.53, Undervalued between -302.53 and -181.91, Fairly Valued between 59.32 and -181.91, Overvalued between 59.32 and 179.94, and Strongly Overvalued above 179.94. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Health Catalyst Inc. (HCAT) has a current P/FCF of 0.00. The 5-year average P/FCF is -74.81. The thresholds are as follows: Strongly Undervalued below -373.23, Undervalued between -373.23 and -224.02, Fairly Valued between 74.39 and -224.02, Overvalued between 74.39 and 223.60, and Strongly Overvalued above 223.60. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Health Catalyst Inc (HCAT) has a current Price-to-Book (P/B) ratio of 0.74. Compared to its 3-year average P/B ratio of 1.26 , the current P/B ratio is approximately -41.36% higher. Relative to its 5-year average P/B ratio of 2.91, the current P/B ratio is about -74.61% higher. Health Catalyst Inc (HCAT) has a Forward Free Cash Flow (FCF) yield of approximately -2.92%. Compared to its 3-year average FCF yield of -3.77%, the current FCF yield is approximately -22.50% lower. Relative to its 5-year average FCF yield of -3.06% , the current FCF yield is about -4.35% lower.

0.69

P/B

Median3y

1.26

Median5y

2.91

-2.96

FCF Yield

Median3y

-3.77

Median5y

-3.06

Competitors Valuation Multiple

The average P/S ratio for HCAT's competitors is 14.07, providing a benchmark for relative valuation. Health Catalyst Inc Corp (HCAT) exhibits a P/S ratio of 0.84, which is -94.01% above the industry average. Given its robust revenue growth of 6.35%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Inspired Entertainment Inc

Performance Decomposition

Market capitalization of HCAT decreased by 52.85% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -17.81 to -50.76.

The secondary factor is the Revenue Growth, contributed 6.35%to the performance.

Overall, the performance of HCAT in the past 1 year is driven by Margin Expansion. Which is more sustainable.

6.35%

75.90M → 80.72M

Revenue Growth

185.01%

-17.81 → -50.76

Margin Expansion

-244.21%

1.53 → -2.21

P/E Change

-52.85%